These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17540161)

  • 1. Opening up the Ivory Tower.
    Wilan KH
    Cell; 2007 Jun; 129(5):847-50. PubMed ID: 17540161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biobusiness on campus: commercialization of university-developed biomedical technologies.
    Dueker KS
    Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry and academia in transition.
    Kennedy D
    Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
    [No Abstract]   [Full Text] [Related]  

  • 4. . . . as NIH tightens up on academic-industry deals.
    Gavaghan H
    Nature; 1994 Jun; 369(6480):430. PubMed ID: 8202121
    [No Abstract]   [Full Text] [Related]  

  • 5. University-industry collaboration. Last of the big-time spenders?
    Lawler A
    Science; 2003 Jan; 299(5605):330-3. PubMed ID: 12531991
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug prices: real problem, wrong solution.
    Kennedy D
    Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914
    [No Abstract]   [Full Text] [Related]  

  • 7. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 8. The triple helix--NIH, industry, and the academic world.
    Lowe CU
    Yale J Biol Med; 1982; 55(3-4):239-46. PubMed ID: 7180024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing innovation: university-industry partnerships and the licensing of the Harvard mouse.
    Blaug S; Chien C; Shuster MJ
    Nat Biotechnol; 2004 Jun; 22(6):761-4. PubMed ID: 15175696
    [No Abstract]   [Full Text] [Related]  

  • 10. Research funding. U.S. biodefense boom: eight new study centers.
    Malakoff D
    Science; 2003 Sep; 301(5639):1450-1. PubMed ID: 12970522
    [No Abstract]   [Full Text] [Related]  

  • 11. Policy directions for the National Heart, Lung, and Blood Institute: implications for academia and industry.
    Lenfant C
    Circulation; 1985 Aug; 72(2 Pt 2):I44-7. PubMed ID: 4006158
    [No Abstract]   [Full Text] [Related]  

  • 12. Universities unnerved by revised rules for sharing NIH research.
    Jennings C
    Nature; 2004 Aug; 430(7003):953. PubMed ID: 15329680
    [No Abstract]   [Full Text] [Related]  

  • 13. NIH restricts university links with industry.
    McGourty C
    Nature; 1989 Sep; 341(6239):173. PubMed ID: 2779663
    [No Abstract]   [Full Text] [Related]  

  • 14. Going for the big one.
    Eisenstein RI; Resnick DS
    Nat Biotechnol; 2001 Sep; 19(9):881-2. PubMed ID: 11533650
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulating scientific research: intellectual property rights and the norms of science.
    Rai AK
    Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
    [No Abstract]   [Full Text] [Related]  

  • 16. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research funding: less should be more.
    Sousa R
    Science; 2008 Nov; 322(5906):1324-5. PubMed ID: 19039118
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent medicine.
    Baker D
    J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309
    [No Abstract]   [Full Text] [Related]  

  • 19. US science policy: upstart states.
    Marris E
    Nature; 2005 Mar; 434(7029):10-2. PubMed ID: 15744265
    [No Abstract]   [Full Text] [Related]  

  • 20. Taking university research into the marketplace.
    Omenn GS
    N Engl J Med; 1982 Sep; 307(11):694-700. PubMed ID: 6955593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.